Myelin basic protein in brains of rats with low dose lead encephalopathy
✍ Scribed by Rolf Sundström; Börje Karlsson
- Publisher
- Springer-Verlag
- Year
- 1987
- Tongue
- English
- Weight
- 575 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0340-5761
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The demyelinative potential of the cytokines interleukin-la (IL-la), interferon-y (IFN-y), and tumor necrosis factor-a (TNF-a) has been investigated in myelinating aggregate brain cell cultures. Treatment of myelinated cultures with these cytokines resulted in a reduction in myelin basic protein (MB
## Abstract The highly encephalitogenic guinea pig peptide 68‐88 has been used to develop an effective and reproducible model of protection in the Lewis rat. Doses as low as 0.1 nmol of peptide protected 70% of rats when injected intraperitoneally six and four weeks prior to challenge with 0.05 nmo
## Abstract In our previous investigations, we demonstrated that CD4^+^ antimyelin basic protein (MBP) T cells protect hippocampal neurons against trimethyltin‐induced damage. We hypothesized involvement of T cells, interacting with the various glial populations activated during the neurodegenerati
Currently used to treat severe acne, 13-cis-retinoic acid (13-cis-RA) is under investigation for its anticancer effects as is the isomer, all-trans-retinoic acid (all-trans-RA). Here, the effects of oral 13-cis-RA or all-trans-RA treatment on serum chemistry, leptin and adiponectin levels were evalu